Skip to earnings analysis
← Back to feed
UHS FY2026 Q1 IN LINE

Universal Health Services, Inc. earnings call

Apr 28, 2026 · 09:00 ET Darren LarrickMark MillerSteve Filton
Buzzberg read

Talkspace acquisition to be accretive within first year

UHS reported Q1 2026 results in line with guidance, with revenue growth of 9.6% and adjusted EPS of $5.62. The core business (ex-DPP) showed negative EBITDA growth, offset by strong pricing, and is expected to ramp sharply for the rest of 2026. Management reiterated full-year guidance and highlighted the Talkspace acquisition and AI efficiencies as key strategic moves. Adjusted EPS of $5.62 beat the prior year by 16.1%, driven partly by $46M in out-of-period DPP benefits.

Buzzberg read Talkspace acquisition to be accretive within first year UHS reported Q1 2026 results in line with guidance, with revenue growth of 9.6% and adjusted EPS of $5.62. The core business (ex-DPP) showed negative EBITDA growth, offset by strong pricing, and is expected to ramp sharply for the rest of 2026. Management reiterated full-year guidance and highlighted the Talkspace acquisition and AI efficiencies as key strategic moves. Adjusted EPS of $5.62 beat the prior year by 16.1%, driven partly by $46M in out-of-period DPP benefits. Read full analysisCollapse analysis

UHS reported Q1 2026 results in line with guidance, with revenue growth of 9.6% and adjusted EPS of $5.62. The core business (ex-DPP) showed negative EBITDA growth, offset by strong pricing, and is expected to ramp sharply for the rest of 2026. Management reiterated full-year guidance and highlighted the Talkspace acquisition and AI efficiencies as key strategic moves. Adjusted EPS of $5.62 beat the prior year by 16.1%, driven partly by $46M in out-of-period DPP benefits.

  • Ex-DPP, core EBITDA growth was negative (~ -5% yoy), below the ~5% full-year target, requiring a significant sequential ramp.
  • Behavioral health volume growth of 1.6% was below the 2-3% target, impacted by weather.
  • HICS patient volume declined 5% yoy, but UHS reserved for a higher effective decline (~10-12%) reflecting anticipated premium non-payment.
Revenue $4.4952B +0% QoQ
EPS $5.62 -4% QoQ
Op margin 11.19% reported
Free cash flow $0.1845B -37% QoQ

What changed this quarter

01
M&A

Talkspace acquisition to be accretive within first year

UHS reported Q1 2026 results in line with guidance, with revenue growth of 9.6% and adjusted EPS of $5.62. The core business (ex-DPP) showed negative EBITDA growth, offset by strong pricing, and is expected to ramp sharply for the rest of 2026. Management reiterated full-year…

02
Costs

Behavioral wage growth moderating from 7-8% to 6%

Adjusted EPS of $5.62 beat the prior year by 16.1%, driven partly by $46M in out-of-period DPP benefits.

03
Payor Mix

HICS decline expected to steepen through 2026

Ex-DPP, core EBITDA growth was negative (~ -5% yoy), below the ~5% full-year target, requiring a significant sequential ramp.

04
AI

AI revenue cycle use cases yielding significant benefits

Management is deploying AI across revenue cycle operations with eight scaled use cases generating significant benefits, and is expanding into clinical operations with new use cases built with Hippocratic AI, expected to be incremental to margins and improve quality and patient…

AI, capex & demand read

AI

Platform & monetization

Management is deploying AI across revenue cycle operations with eight scaled use cases generating significant benefits, and is expanding into clinical operations with new use cases built with Hippocratic AI, expected to be incremental to margins and improve quality and patient experience over time.

Demand

Bookings & conversion

March volumes normalized after weather and flu impact. Management expressed confidence in their strategic initiatives, reiterated full-year guidance, and highlighted strong demand and operational progress despite seasonal headwinds.

Capex

Investment and capacity

Capital expenditures remain robust, funding new de novo hospitals, bed towers, and replacement projects across acute and behavioral segments, with several facilities opening in 2026. The company also expanded credit facility capacity by $900 million to support the Talkspace acquisition and continue buybacks.

Tone · Confident

Management expressed confidence in their strategic initiatives, reiterated full-year guidance, and highlighted strong demand and operational progress despite seasonal headwinds.

Supply-chain alpha

A1

Core EBITDA growth was negative in Q1 2026 (~5% decline) ex-DPP, significantly below the ~5% full-year guidance, meaning the rest of the year requires a substantial sequential ramp.

“I acknowledge I'm not going to agree to all your numbers... we're not at that core 5% growth, excluding all the DPP and other non-recurring items in the corridor but still believe that we're going to get there for the full year.”
Steve Filton
A2

UHS recorded a higher effective HICS decline (~10-12%) than the reported 5% by reserving for patients who will likely fail to make premiums, signaling an accelerating negative HICS mix trend.

“We recorded an additional reserve because we believe that some of those HICS patients... will later be deemed not to have coverage because they failed to make their premium payments.”
Steve Filton
A3

UHS expects Florida's 2025 Medicaid supplemental payment program to be approved imminently with potential benefit 'measurably higher' than the estimated $50 million.

“We have a high level of confidence amongst providers in Florida... when we see the final approvals, we believe that benefit could be measurably higher.”
Steve Filton
A4

Behavioral health same-facility wages per adjusted patient day grew ~6% in Q1, moderating from the 7-8% level in 2025, but still high.

“same-facility salaries, wages, and benefits for adjusted patient day increased by approximately 6% on a year-over-year basis, moderating slightly from the 7% to 8% level we experienced during 2025.”
Steve Filton

Company read-throughs

+1.4%
since call
$5.18$5.25
Supply chain

UHS is acquiring Talkspace to create an end-to-end behavioral continuum, accelerating its outpatient strategy.

“Talkspace is an established market leader in virtual outpatient behavioral health care with a network of 6,000 licensed professionals serving all 50 states.”
Mark Miller